DARA BioSciences Announces Specialty Oncology Care Platform

DARA BioSciences.

announced today it has a completed a series of agreements with a number of specialty pharmacy providers, leading group purchasing organizations (GPOs), retail partners, reimbursement experts, and an industry-leading third-party logistics provider. DARA believes these agreements provide the company comprehensive commercial coverage across the national oncology market. As part of an integrated national network with annual sales of over $1 billion in cancer therapeutics, DARA has significantly enhanced its commercial scale and capabilities. Its distribution network now consists of more than 45,000 retail pharmacies, mail order pharmacies, and